Author:
Furue Masutaka,Ito Takamichi,Wada Naoko,Wada Maiko,Kadono Takafumi,Uchi Hiroshi
Publisher
Springer Science and Business Media LLC
Reference64 articles.
1. Ernst DS, Petrella T, Joshua AM, Hamou A, Thabane M, Vantyghem S, et al. Burden of illness for metastatic melanoma in Canada, 2011-2013. Curr Oncol. 2016;23(6):e563–e70.
https://doi.org/10.3747/co.23.3161
.
2. Gwadry-Sridhar F, Nikan S, Hamou A, Seung SJ, Petrella T, Joshua AM, et al. Resource utilization and costs of managing patients with advanced melanoma: a Canadian population-based study. Curr Oncol. 2017;24(3):168–75.
https://doi.org/10.3747/co.24.3432
.
3. Szczepaniak Sloane RA, Gopalakrishnan V, Reddy SM, Zhang X, Reuben A, Wargo JA. Interaction of molecular alterations with immune response in melanoma. Cancer. 2017;123(S11):2130–42.
https://doi.org/10.1002/cncr.30681
.
4. World Health Organization, International Agency on Cancer Research (iarc). GLOBOCAN 2008: Cancer incidence and mortality worldwide in 2008 [Web resource]. Lyon, France: iarc: 2008. [Current version (2012) available online at:
http://globocan.iarc.fr/Default.aspx
; cited 5 Mar 2016].
5. Garbe C, Eigentler TK, Keilholz U, Hauschild A, Kirkwood JM. Systematic review of medical treatment in melanoma: current status and future prospects. Oncologist. 2011;16(1):5–24.
https://doi.org/10.1634/theoncologist.2010-0190
.
Cited by
47 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献